Genomics & Biotechnology

ETC Group has tracked developments in the genetic engineering of plants, animals and microorganisms since the early 1980s and tracked the transition of the biotechnology industry into a broader 'life sciences' industry spanning agriculture, pharmaceuticals, energy and chemicals production. Today, biotechnology encompasses a variety of techniques that involve the use and manipulation of living organisms to make commercial products (including cell and tissue culture, recombinant DNA technology and synthetic biology). Underlying the commercial manipulation of life are ever more powerful genomics technologies (gene-mapping) that enable companies to quickly 'read,' store and digitally analyze genetic information -- either of single organisms or entire ecosystems (known as metagenomics). ETC Group (then RAFI) was one of the first organizations to warn of the downside of genetic engineering of crops and livestock and has since kept an eye on developments in human biotech, synthetic biology, biowarfare and industrial biotech.

Featured Content

An efficient, transparent pathway for technological advancement would save national governments time and money while reducing risk. Those proposing new technologies and their backers seek to minimize risk. Especially, re-insurers and investors welcome steps that make government intervention and/or public responses predictable.

 
Problems, Fascinations and Opportunities: A Preface
 

A new report by the ETC Group concludes that the social, environmental and bio-weapons threats of synthetic biology surpass the possible dangers and abuses of biotech. The full text of the 70-page report, Extreme Genetic Engineering: An Introduction to Synthetic Biology, is available for downloading free-of-charge on the ETC Group website.